Oracle ended its fiscal third quarter with $553 billion in remaining purchase obligations -- up 325% year over year.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The 40-card oracle deck was born out of the relationship the illustrator and writer formed while on a trip to Egypt. We took ...

Several global giants listed as victims of the Oracle EBS hack have remained mum on the impact of the cybersecurity incident.

Oracle Fin Serv Standalone December 2025 Net Sales at Rs 1,452.70 crore, up 11.28% Y-o-Y Jan 22 2026 01:19 PM Oracle Fin Serv Standalone December 2025 Net Sales at Rs 1,452.70 crore, up 11.28% Y-o-Y ...

Nvidia disclosed in recent regulatory filings that it had fully exited its roughly two‑year, 7.71 million‑share investment in Recursion Pharmaceuticals, while Cathie Wood’s ARK Invest simultaneously ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.